세계의 예방 헬스케어 기술 및 서비스 시장 : 유형별, 모델 유형별, 용도별 예측(2025-2030년)

The Preventive Healthcare Technologies & Services Market was valued at USD 81.23 billion in 2023, expected to reach USD 89.48 billion in 2024, and is projected to grow at a CAGR of 10.63%, to USD 164.80 billion by 2030.

Preventive healthcare technologies and services encompass a broad range of solutions designed to avert illnesses before they manifest as serious health issues, thereby improving quality of life and reducing healthcare costs. Necessity for such technologies arises due to increasing prevalence of chronic diseases, aging populations, and escalating healthcare expenses. Applications include genetic testing, predictive analytics, telemedicine, wearable devices, vaccines, and health education programs, targeting end-uses across individuals, healthcare providers, and insurers. Growth in this market is primarily driven by increased awareness of health benefits, advancements in technology, and supportive government policies favoring preventive measures over curative treatments. Notable opportunities emerge in personalized preventive solutions, data-driven health insights, and integration of AI in early diagnosis tools, where businesses can gain competitive advantage by focusing on consumer-centric products and robust data security measures. However, challenges such as high cost of innovation, regulatory hurdles, fragmented healthcare systems, and data privacy concerns impede rapid progress. Moreover, skepticism and misinformation about preventive measures can also limit market expansion. Companies should invest in educating consumers, fostering collaborative ecosystems, and prioritizing interoperable technologies to overcome these challenges. Areas ripe for innovation include AI and IoT applications for health monitoring, genetic risk profiling, and scalable digital health platforms offering virtual consultations and real-time disease management. The nature of this market leans towards dynamic evolution, driven by technological advancements, consumer behavior shifts, and policy changes, demanding ongoing adaptation and strategic foresight. To bolster growth, businesses ought to explore partnerships with tech firms, healthcare providers, and policymakers, while maintaining a keen focus on regulatory compliance and ethical data handling. By tapping into these strategies, organizations can effectively harness the potential of preventive healthcare technologies, ensuring sustainable advancement and enhanced public health outcomes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Preventive Healthcare Technologies & Services Market

The Preventive Healthcare Technologies & Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of lifestyle-associated and other chronic diseases
  • Adoption of advanced technology and the development of preventive measures, including screening & monitoring devices, vaccines, and smart devices
  • R&D investment and commercialization efforts for vaccines
• Market Restraints
  • High initial installation cost associated with preventive healthcare technologies
• Market Opportunities
  • Development of the advanced technology for preventive healthcare in emerging market
  • Increasing number of awareness campaigns and programs by the government
• Market Challenges
  • Dearth of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Preventive Healthcare Technologies & Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Preventive Healthcare Technologies & Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Preventive Healthcare Technologies & Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Preventive Healthcare Technologies & Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Preventive Healthcare Technologies & Services Market

A detailed market share analysis in the Preventive Healthcare Technologies & Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Preventive Healthcare Technologies & Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Preventive Healthcare Technologies & Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Preventive Healthcare Technologies & Services Market

A strategic analysis of the Preventive Healthcare Technologies & Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Preventive Healthcare Technologies & Services Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alere Inc., Biocon Limited, Dilon Technologies, Inc., GlaxoSmithKline PLC, Healthways, Inc., McKesson Corporation, Medtronic PLC, Merck & Co., Inc., Omnicell, Inc., Pfizer, Inc., Quest Diagnostics, Inc., Sanofi S.A., Scripto LLC, Serum Institute of India Private Limited, and Tivity Health, Inc.

Market Segmentation & Coverage

This research report categorizes the Preventive Healthcare Technologies & Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Chronic Disease Management Technologies, Early Detection & Screening Technologies, and Vaccines. The Chronic Disease Management Technologies is further studied across Asthma Monitors, Blood Pressure Monitors, Cardiovascular Monitors, and Glucose Monitors. The Early Detection & Screening Technologies is further studied across Automated Screening and Personalized Medicine. The Vaccines is further studied across Allergy Vaccine, Autism Vaccine, Cancer Vaccine, and Infectious Diseases Vaccine.
• Based on Model Type, market is studied across Hybrid Management Model, In-House Management Model, and Outsourced Management.
• Based on Application, market is studied across Clinics and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of lifestyle-associated and other chronic diseases
    • 5.1.1.2. Adoption of advanced technology and the development of preventive measures, including screening & monitoring devices, vaccines, and smart devices
    • 5.1.1.3. R&D investment and commercialization efforts for vaccines
  • 5.1.2. Restraints
    • 5.1.2.1. High initial installation cost associated with preventive healthcare technologies
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of the advanced technology for preventive healthcare in emerging market
    • 5.1.3.2. Increasing number of awareness campaigns and programs by the government
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of skilled professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Preventive Healthcare Technologies & Services Market, by Type

• 6.1. Introduction
• 6.2. Chronic Disease Management Technologies
  • 6.2.1. Asthma Monitors
  • 6.2.2. Blood Pressure Monitors
  • 6.2.3. Cardiovascular Monitors
  • 6.2.4. Glucose Monitors
• 6.3. Early Detection & Screening Technologies
  • 6.3.1. Automated Screening
  • 6.3.2. Personalized Medicine
• 6.4. Vaccines
  • 6.4.1. Allergy Vaccine
  • 6.4.2. Autism Vaccine
  • 6.4.3. Cancer Vaccine
  • 6.4.4. Infectious Diseases Vaccine

7. Preventive Healthcare Technologies & Services Market, by Model Type

• 7.1. Introduction
• 7.2. Hybrid Management Model
• 7.3. In-House Management Model
• 7.4. Outsourced Management

8. Preventive Healthcare Technologies & Services Market, by Application

• 8.1. Introduction
• 8.2. Clinics
• 8.3. Hospitals

9. Americas Preventive Healthcare Technologies & Services Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Preventive Healthcare Technologies & Services Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Preventive Healthcare Technologies & Services Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Alere Inc.
• 3. Biocon Limited
• 4. Dilon Technologies, Inc.
• 5. GlaxoSmithKline PLC
• 6. Healthways, Inc.
• 7. McKesson Corporation
• 8. Medtronic PLC
• 9. Merck & Co., Inc.
• 10. Omnicell, Inc.
• 11. Pfizer, Inc.
• 12. Quest Diagnostics, Inc.
• 13. Sanofi S.A.
• 14. Scripto LLC
• 15. Serum Institute of India Private Limited
• 16. Tivity Health, Inc